We randomly allocated Ugandan children aged 1-10 years with uncomplicated falciparum malaria and normal G6PD enzyme function to receive artemether-lumefantrine , combined with either placebo or with 0.1 mg/kg , 0.4 mg/kg , or 0.75 mg/kg ( WHO reference dose ) primaquine base .